Effect of pioglitazone on serum concentrations of osteoprotegerin in patients with type 2 diabetes mellitus

OBJECTIVE: Osteoprotegerin (OPG) acts as an important regulatory molecule in atherosclerosis. Recent studies report that thiazolidinediones could affect OPG expression. We investigated the relationship between OPG and inflammatory cytokines and the effects of pioglitazone (a PPARγ (PPARG) agonist) v...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jong Suk, Cho, Min Ho, Nam, Ji Sun, Yoo, Jeong Seon, Ahn, Chul Woo, Cha, Bong Soo, Kim, Kyung Rae, Lee, Hyun Chul
Formato: Texto
Lenguaje:English
Publicado: BioScientifica 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000683/
https://www.ncbi.nlm.nih.gov/pubmed/20961967
http://dx.doi.org/10.1530/EJE-10-0875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3000683/
https://www.ncbi.nlm.nih.gov/pubmed/20961967
http://dx.doi.org/10.1530/EJE-10-0875

Ejemplares similares